Detalhe da pesquisa
1.
Cocktail party: Low-dose antibody combinations deliver pan-ebolavirus protection.
Cell
; 185(6): 943-945, 2022 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35303426
2.
Structural and functional characterizations of infectivity and immune evasion of SARS-CoV-2 Omicron.
Cell
; 185(5): 860-871.e13, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35120603
3.
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2.
Cell
; 185(5): 896-915.e19, 2022 03 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35180381
4.
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic.
Cell
; 185(3): 447-456.e11, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35026151
5.
Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection.
Cell
; 184(7): 1858-1864.e10, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33631096
6.
The antigenic anatomy of SARS-CoV-2 receptor binding domain.
Cell
; 184(8): 2183-2200.e22, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33756110
7.
Compromised SARS-CoV-2-specific placental antibody transfer.
Cell
; 184(3): 628-642.e10, 2021 02 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33476549
8.
SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2.
Cell
; 184(15): 3936-3948.e10, 2021 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-34192529
9.
Pan-ebolavirus protective therapy by two multifunctional human antibodies.
Cell
; 184(22): 5593-5607.e18, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34715022
10.
Pan-protective anti-alphavirus human antibodies target a conserved E1 protein epitope.
Cell
; 184(17): 4414-4429.e19, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416146
11.
Therapeutic alphavirus cross-reactive E1 human antibodies inhibit viral egress.
Cell
; 184(17): 4430-4446.e22, 2021 08 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416147
12.
Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques.
Cell
; 184(13): 3467-3473.e11, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34133941
13.
An infectivity-enhancing site on the SARS-CoV-2 spike protein targeted by antibodies.
Cell
; 184(13): 3452-3466.e18, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34139176
14.
Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant.
Cell
; 184(13): 3426-3437.e8, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33991487
15.
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera.
Cell
; 184(8): 2201-2211.e7, 2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743891
16.
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
Cell
; 184(9): 2384-2393.e12, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794143
17.
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection.
Cell
; 184(7): 1804-1820.e16, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691139
18.
Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.
Cell
; 184(9): 2372-2383.e9, 2021 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33743213
19.
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
Cell
; 184(5): 1171-1187.e20, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33621484
20.
High-resolution profiling of pathways of escape for SARS-CoV-2 spike-binding antibodies.
Cell
; 184(11): 2927-2938.e11, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34010620